The establishment of EVISA is funded by the EU through
the Fifth Framework Programme (G7RT- CT- 2002- 05112).
Supporters of EVISA includes:
The judicious use of chelating (metal binding) agents for the removal
of toxic amounts of metal ions from living organisms. The metal ions
are sequestered by the chelating agents and are rendered harmless or
excreted. Chelating agents such as 2,3-dimercaptopropan-1-ol,
ethylenediaminetetraacetic acid, desferrioxamine and D-penicillamine
have been used effectively in chelation therapy for arsenic, lead, iron
and copper, respectively.
The term "chelation therapy" was found in the following pages: